IBDEI3BN ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1733,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^134
 ;;^UTILITY(U,$J,358.4,1734,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^134
 ;;^UTILITY(U,$J,358.4,1735,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^134
 ;;^UTILITY(U,$J,358.4,1736,0)
 ;;=PARAPHILIC DISORDERS^21^134
 ;;^UTILITY(U,$J,358.4,1737,0)
 ;;=PERSONALITY DISORDERS^23^134
 ;;^UTILITY(U,$J,358.4,1738,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^134
 ;;^UTILITY(U,$J,358.4,1739,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^134
 ;;^UTILITY(U,$J,358.4,1740,0)
 ;;=RELATIONAL PROBLEMS^25^134
 ;;^UTILITY(U,$J,358.4,1741,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^134
 ;;^UTILITY(U,$J,358.4,1742,0)
 ;;=SEXUAL DYSFUNCTIONS^27^134
 ;;^UTILITY(U,$J,358.4,1743,0)
 ;;=SLEEP-WAKE DISORDERS^28^134
 ;;^UTILITY(U,$J,358.4,1744,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^134
 ;;^UTILITY(U,$J,358.4,1745,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^134
 ;;^UTILITY(U,$J,358.4,1746,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^134
 ;;^UTILITY(U,$J,358.4,1747,0)
 ;;=SUBSTANCE DISORDER-OPIOID^36^134
 ;;^UTILITY(U,$J,358.4,1748,0)
 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^134
 ;;^UTILITY(U,$J,358.4,1749,0)
 ;;=SUBSTANCE DISORDER-TOBACCO^39^134
 ;;^UTILITY(U,$J,358.4,1750,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^134
 ;;^UTILITY(U,$J,358.4,1751,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^134
 ;;^UTILITY(U,$J,358.4,1752,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^134
 ;;^UTILITY(U,$J,358.4,1753,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^134
 ;;^UTILITY(U,$J,358.4,1754,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^134
 ;;^UTILITY(U,$J,358.4,1755,0)
 ;;=ELIMINATION DISORDERS^11^134
 ;;^UTILITY(U,$J,358.4,1756,0)
 ;;=GAMBLING DISORDER^13^134
 ;;^UTILITY(U,$J,358.4,1757,0)
 ;;=OTHER MENTAL DISORDERS^20^134
 ;;^UTILITY(U,$J,358.4,1758,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^134
 ;;^UTILITY(U,$J,358.4,1759,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^134
 ;;^UTILITY(U,$J,358.4,1760,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^134
 ;;^UTILITY(U,$J,358.4,1761,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^134
 ;;^UTILITY(U,$J,358.4,1762,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^134
 ;;^UTILITY(U,$J,358.4,1763,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^134
 ;;^UTILITY(U,$J,358.4,1764,0)
 ;;=INPT H&P-NEW ADMISSION^4^135
 ;;^UTILITY(U,$J,358.4,1765,0)
 ;;=INITIAL OBSERVATION^1^135
 ;;^UTILITY(U,$J,358.4,1766,0)
 ;;=INPT CONSULTATIONS^5^135
 ;;^UTILITY(U,$J,358.4,1767,0)
 ;;=INPT-ESTABLISHED PATIENT CARE^6^135
 ;;^UTILITY(U,$J,358.4,1768,0)
 ;;=INPT DISCHARGES^7^135
 ;;^UTILITY(U,$J,358.4,1769,0)
 ;;=SUBSEQUENT OBSERVATION^2^135
 ;;^UTILITY(U,$J,358.4,1770,0)
 ;;=OBSERVATION DISCHARGE^3^135
 ;;^UTILITY(U,$J,358.4,1771,0)
 ;;=INJECTIONS/DRUGS^7^136
 ;;^UTILITY(U,$J,358.4,1772,0)
 ;;=WOUND CARE^15^136
 ;;^UTILITY(U,$J,358.4,1773,0)
 ;;=MD PROCEDURES^1^136
 ;;^UTILITY(U,$J,358.4,1774,0)
 ;;=MUSCLE NERVE TESTS^9^136
 ;;^UTILITY(U,$J,358.4,1775,0)
 ;;=TEAM CONFERENCE^12^136
 ;;^UTILITY(U,$J,358.4,1776,0)
 ;;=ACUPUNCTURE^2^136
 ;;^UTILITY(U,$J,358.4,1777,0)
 ;;=CHEMODENERVATION^6^136
 ;;^UTILITY(U,$J,358.4,1778,0)
 ;;=OTHER^10^136
 ;;^UTILITY(U,$J,358.4,1779,0)
 ;;=BACLOFEN PUMP^3^136
 ;;^UTILITY(U,$J,358.4,1780,0)
 ;;=BOTOX^4^136
 ;;^UTILITY(U,$J,358.4,1781,0)
 ;;=CARPAL TUNNEL INJECTION^5^136
 ;;^UTILITY(U,$J,358.4,1782,0)
 ;;=JNT BURSA INJ W/ US^8^136
 ;;^UTILITY(U,$J,358.4,1783,0)
 ;;=TRIGGER POINT INJECTION^13^136
 ;;^UTILITY(U,$J,358.4,1784,0)
 ;;=ULTRASOUND^14^136
